Stone Ridge Asset Management’s AngioDynamics ANGO Stock Holding History

Stone Ridge Asset Management’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-14,153	Closed	-$144K	–	27
2020 Q2	$144K	Buy	14,153 +4,000	+39%	+$41.2K	0.02%	544
2020 Q1	$106K	Buy	+10,153	New	+$127K	0.01%	691
2019 Q4	–	Sell	-34,598	Closed	-$637K	–	947
2019 Q3	$637K	Sell	34,598 -3,810	-10%	-$74.5K	0.04%	577
2019 Q2	$756K	Hold	38,408	–	–	0.04%	531
2019 Q1	$878K	Sell	38,408 -800	-2%	-$17.4K	0.05%	484
2018 Q4	$789K	Sell	39,208 -400	-1%	-$8.28K	0.05%	541
2018 Q3	$861K	Buy	39,608 +400	+1%	+$8.88K	0.05%	556
2018 Q2	$872K	Sell	39,208 -500	-1%	-$10.2K	0.05%	491
2018 Q1	$685K	Buy	39,708 +500	+1%	+$8.34K	0.04%	597
2017 Q4	$652K	Buy	+39,208	New	+$669K	0.04%	638

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Stone Ridge Asset Management's ANGO Position: Q3 2020 in Review

Stone Ridge Asset Management sold out of AngioDynamics (ANGO) in Q3 2020, closing a stake of 14,153 shares — an estimated $144K sold.

Stone Ridge Asset Management first reported a position in ANGO in Q4 2017 and held it in 10 quarters. The position peaked at $878K in Q1 2019. 138 funds tracked by Wall St. Rank hold ANGO as of Q3 2020.

Stone Ridge Asset Management reported no remaining AngioDynamics position as of Q3 2020 after selling out during the quarter.
Stone Ridge Asset Management sold 14,153 AngioDynamics shares in Q3 2020, an estimated $144K.
Stone Ridge Asset Management first reported a position in AngioDynamics in Q4 2017 and held it in 10 quarters.
Stone Ridge Asset Management's AngioDynamics position peaked at $878K in Q1 2019.
138 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2020.

Based on Stone Ridge Asset Management's 13F filing for Q3 2020.